MPM BioImpact’s investment team consists of professionals who have dedicated their careers to research and drug development, company creation, corporate strategy, and commercialization. Our Entrepreneur Partners provide deep domain expertise as investor-operators and work with our diverse group of scientists and professionals to develop therapies for diseases with high unmet needs. Collectively, we are a team of deeply experienced company creators who help transform scientific discoveries into breakthrough medicines for the patients that need them most.
Learn about our team of expertsInvesting
in the Future
of Medicine
We create and invest in biotech companies with innovative technologies that are developing life-saving drugs for patients. We invest in both private and public companies, providing a unique longitudinal view of drug development across the industry.
30+
Years of Biotech Investing
60
FDA-approved drugs
41
Companies founded since 2010*
*Companies created by MPM BioImpact include portfolio companies where MPM BioImpact was a co-founder or early lead investor from 2010 to today, representing the period that MPM BioImpact’s strategy has been focused on company creation.
We are Company Creators
We built Orna Therapeutics to create a new class of coding RNA medicines that outperforms mRNA.
Orna’s circular RNA technology (oRNA) and best-in-class non-viral delivery are fundamentally changing the landscape of treatment modalities,* starting with replacing cell therapies in autoimmune diseases and oncology indications.
"We are proud to have created and built Orna based on groundbreaking research that came out of MIT. Orna is combining its proprietary circular RNA platform with industry leading delivery technology to create transformative medicines using the panCAR approach.”**
Ansbert Gadicke, M.D.
Chairman
Joseph Bolen, Ph.D.
Chief Scientific Officer
Frank Neumann, M.D., Ph.D.
Chief Medical Officer*Garber, K., "Orna Therapeutics: circular logic," Nature Biotechnology, 05 August 2022, https://doi.org/10.1038/d41587-022-00005-1
**Quotes are provided for the purpose of recruiting executives and academics to partner with MPM BioImpact. The quotes are provided by individuals who have a business and/or economic relationship with MPM BioImpact, and are not intended to solicit or offer investment advisory services.
Meet our Team
